Source comparison
Ipamorelin vs Sermorelin Which Better Comparison
Mechanism Selective ghrelin receptor (GHS-R1a) agonist GHRH receptor agonist (amplifies endogenous pulses) Ipamorelin is mechanistically independent; sermorelin is rhythm-dependent GH Peak Amplitude 2.5–4× baseline (12–15 ng/mL typical) 5–8× baseline (18–22 ng
This comparison does not assign a generated winner or score.
- Mechanism
- Selective ghrelin receptor (GHS-R1a) agonist
- GHRH receptor agonist (amplifies endogenous pulses)
- Ipamorelin is mechanistically independent; sermorelin is rhythm-dependent
- GH Peak Amplitude
- 2.5–4× baseline (12–15 ng/mL typical)
- 5–8× baseline (18–22 ng/mL typical, higher variance)
- Sermorelin hits harder when timed correctly; ipamorelin is more consistent
- Time to Peak
- 30 minutes post-administration
- 60 minutes post-administration
- Ipamorelin acts faster. Advantage in time-sensitive protocols
- Cortisol/Prolactin Effect
- No measurable elevation
- Mild transient elevation possible at high doses
- Ipamorelin is cleaner for metabolic and body composition research
- Dosing Frequency
- 2–3× daily without desensitization
- Once daily (timed to natural GH peak)
- Ipamorelin offers more flexible dosing schedules
- Side Effect Frequency
- Minimal (transient hunger only)
- Low but present (flushing, headache 10–20% of users)
- Both well-tolerated; ipamorelin has slight edge in compliance
- Half-Life
- Approximately 2 hours
- Approximately 10–20 minutes (requires careful timing)
- Ipamorelin's longer half-life simplifies administration logistics
- Bottom Line
- Best for selectivity, repeatability, minimal disruption
- Best for maximum amplitude GH response in rhythm-optimized protocols
- Choose ipamorelin for precision; choose sermorelin for power when timing is controlled